Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    breaking news emails

    . .the science behind the 'yanny vs. laurel' debate (& who's right!) .resize font . . at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire. . .